|Bid||0.00 x 1200|
|Ask||0.00 x 900|
|Day's Range||136.37 - 141.71|
|52 Week Range||99.14 - 156.66|
|Beta (3Y Monthly)||0.75|
|PE Ratio (TTM)||36.71|
|Earnings Date||Nov 4, 2019|
|Forward Dividend & Yield||1.48 (1.05%)|
|1y Target Est||168.50|
DUBLIN, IRELAND, Oct. 22, 2019 -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2020 second.
How do we determine whether Steris Plc (NYSE:STE) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors in the world, who spend immense amounts of time and resources studying companies. They may not always be right (no one is), but data shows that […]
When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see STERIS plc...
Dublin, Ireland, Aug. 26, 2019 -- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the Morgan Stanley Global Healthcare Conference on.
Today we'll look at STERIS plc (NYSE:STE) and reflect on its potential as an investment. In particular, we'll consider...
President & CEO of Steris Plc (30-Year Financial, Insider Trades) Walter M Rosebrough Jr (insider trades) sold 102,500 shares of STE on 08/08/2019 at an average price of $151.78 a share. Continue reading...
Steris (STE) delivered earnings and revenue surprises of 10.81% and 3.46%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
STERIS plc (STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2020 first quarter ended June 30, 2019. Revenue as reported for the quarter increased 9% to $696.8 million compared with $638.8 million in the first quarter of fiscal 2019, with growth across all segments. Constant currency organic revenue (see Non-GAAP Financial Measures) growth was 10% for the first quarter of fiscal 2020.
Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
For those unable to listen to the conference call live, a replay will be available beginning at 12:00 p.m. Eastern Time on August 6, 2019, either over the Internet at www.steris-ir.com or via phone. To access the replay of the call, please use the access code 10133575 and dial 1-877-344-7529 in the United States or 1-412-317-0088 internationally. STERIS’s mission is to HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe.
Insulet (PODD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Every investor in STERIS plc (NYSE:STE) should be aware of the most powerful shareholder groups. Generally speaking...
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not gamble the hard-earned money of the people who are on the edge of poverty. Truth […]